Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating cannabidiol as a treatment for post-traumatic stress disorder with comorbid traumatic brain injury; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: NYU Langone Health | Conditions: Post Traumatic Stress Disorder, Traumatic Brain Injury | Phase 2 | Status: RECRUITING